SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant volatility following a major seven billion dollar equity and equity-linked offering intended to fund approximately thirty-nine billion dollars in new AI server orders. While management cites the capital raise as a necessary step to secure components and scale for massive demand, the community remains deeply divided, with many investors concerned about share dilution and the stock's long-term reliance on frequent financing versus organic growth.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is seeing heightened volatility and active community discussion ahead of its earnings report, with sentiment split between those targeting a potential short squeeze due to high short interest and others concerned about declining foot traffic and ongoing turnaround challenges. Traders are closely monitoring the stock's ability to maintain recent support levels, while the broader conversation remains fixated on the company's executive leadership and the effectiveness of its recent operational changes.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is experiencing high trading volume and volatility as investors position themselves ahead of the ASCO 2026 plenary session, where highly anticipated overall survival data for its lead drug candidate, ivonescimab, will be presented. The community is actively discussing the stock's potential for a significant short squeeze, the strong insider buying record, and the strategic importance of the upcoming clinical trial readouts for future commercialization or acquisition.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is trending as volatility in the energy sector intensifies following heightened tensions in the Strait of Hormuz, with market participants debating whether the geopolitical risk premiums are sustainable or if looming supply increases will lead to a correction. The community is actively parsing conflicting signals between official ceasefire reports and reports of naval confrontations, leaving traders divided on whether to buy the dip or hedge against a potential pullback in crude oil prices.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as investors debate the impact of AI on its infrastructure, with sentiment split between excitement over its role as a backbone for autonomous AI agents and anxiety regarding workforce restructuring. The community is actively weighing the potential for long-term growth against short-term margin pressures and the evolving threat landscape in the cybersecurity sector.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as it records over $7 billion in special charges to restructure its EV portfolio and China operations, joining industry peers in a strategic pullback from electric vehicle manufacturing. Investors are focused on the company's financial flexibility, including its recent dividend hike and stock buyback program, while debating the long-term impact of pivoting resources back toward high-margin trucks and SUVs.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is capturing investor attention following positive Phase 1 data for its subcutaneous Briumvi treatment in Myasthenia Gravis, which supports the potential for a broader addressable market. The stock remains a focal point for the community due to persistent buyout speculation and active discussions regarding the drug's competitive advantage over existing MS therapies.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors debate the potential impact of upcoming federal rescheduling hearings against the company's aggressive pivot toward an alcohol-focused strategy. The community remains deeply polarized, with many expressing significant frustration over ongoing dilution and share price volatility while others highlight the potential for long-term growth through global infrastructure and beverage expansion.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing intense investor interest as the market prepares for a significant PDUFA decision on April 30 for the potential label expansion of Auvelity into Alzheimer's disease agitation. The community is actively discussing the drug's breakthrough therapy designation, the lack of effective alternatives for this condition, and the expectation that a successful approval could serve as a major catalyst for long-term growth and potential M&A activity.

WorldFinancial

WorldFinancial (WLFI) is trending as investors debate an ongoing governance vote to lock up significant portions of the token supply amidst a wave of negative sentiment, public lawsuits, and allegations of project mismanagement. Community discourse remains deeply divided between those anticipating a supply shock-driven recovery and others labeling the project a failing venture tied to controversial political figures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.

ADXSAdvaxis, Inc.

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest ADXS News